Gerald Jäger

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

Mario Cazzola, Diethelm Messinger, Vittorio Battistel et al. · Blood · 1995 · 222 citations

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma

Anders Österborg, MA Boogaerts, R Cimino et al. · Blood · 1996 · 206 citations · Full text

Treatment of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type With Cladribine: A Phase II Study

Gerald Jäger, Peter Neumeister, Ruth I. Brezinschek et al. · Journal of Clinical Oncology · 2002 · 137 citations

Rituximab for Treatment of Advanced Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Lymphoma

Markus Raderer, Gerald Jäger, Stefan Brugger et al. · Oncology · 2003 · 122 citations

First-line treatment of Waldenström's disease with cladribine

Michael Fridrik, Gerald Jäger, C. Baldinger et al. · Annals of Hematology · 1997 · 60 citations

Medicine, First-line Treatment, Treatment Option +1